Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

96
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
96
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variability in epilepsy polygenic risk prediction across Taiwanese population and clinical cohorts.

Epilepsia·2026
Same author

Detecting Basilar Artery Wall Pathology in Isolated Pontine Infarction With Short-TE SWI Magnitude Images.

Stroke (Hoboken, N.J.)·2026
Same author

Interpretable machine learning based decision tree model for predicting obstructive airway disease in a large non-smoking health screening population.

Scientific reports·2026
Same author

Early Detection of Dementia Through Spectralis Optical Coherence Tomography in a Taiwanese Cohort.

Diagnostics (Basel, Switzerland)·2026
Same author

Efficient artifact removal for adaptive deep brain stimulation and a temporal event localization analysis.

Journal of neuroscience methods·2026
Same author

Refining postoperative quality metrics: risk factors for emergency department visits within 3 days after hemorrhoidectomy.

Perioperative medicine (London, England)·2025
Same journal

Methods for incorporating test result information within the high-dimensional propensity score framework: application in UK electronic health record data.

BMC medical research methodology·2026
Same journal

Sparse multi-way DMDC for longitudinal classification in high dimension low sample size data.

BMC medical research methodology·2026
Same journal

Tree-based exploratory identification of predictive biomarkers in non-randomized data.

BMC medical research methodology·2026
Same journal

Comparative evaluation of interrupted time series analytical methods for healthcare quality improvement research: a Monte Carlo simulation study.

BMC medical research methodology·2026
Same journal

Methodological advances in claims-based dementia algorithms: integrating medication and clinical data for medicare populations.

BMC medical research methodology·2026
Same journal

An interpretable XGboost algorithm for predicting 30-day mortality in acute pancreatitis using routine biomarkers.

BMC medical research methodology·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

957

Establishing a machine learning dementia progression prediction model with multiple integrated data.

Yung-Chuan Huang1, Tzu-Chi Liu2, Chi-Jie Lu3,4,5,6

  • 1Department of Neurology, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, Taiwan.

BMC Medical Research Methodology
|November 23, 2024
PubMed
Summary
This summary is machine-generated.

Machine learning accurately predicts dementia progression using clinical and lab data. The XGBoost model identified eight key variables, offering valuable clinical guidance for managing degenerative dementia.

Keywords:
DementiaExtreme gradient boostingMachine learningPrediction model

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.1K

Related Experiment Videos

Last Updated: Jun 6, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

957
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.1K

Area of Science:

  • Neurology
  • Artificial Intelligence
  • Data Science

Background:

  • Dementia presents a significant global health challenge, necessitating effective tools for predicting disease progression.
  • Machine learning (ML) offers a powerful approach to developing predictive models from complex, real-world clinical data.

Purpose of the Study:

  • To develop and validate a machine learning model for predicting the progression of degenerative dementia.
  • To identify key clinical and demographic variables that are most predictive of dementia progression.

Main Methods:

  • Retrospective analysis of 679 patients with degenerative dementia, followed for over two years.
  • Utilized the extreme gradient boosting (XGB) model to analyze demographic, clinical dementia rating (CDR), mini-mental state examination (MMSE), and laboratory data (LV) variables.
  • Employed a step-wise approach to identify optimal feature combinations and variable importance.

Main Results:

  • The integrated D-CDR-MMSE-LV model achieved a high area under the receiver operating characteristic curve (AUC) of 85.12.
  • The XGBoost model identified eight critical variables from the integrated datasets.
  • The model demonstrated robust performance with high sensitivity (84.66).

Conclusions:

  • A machine learning model was successfully developed to monitor dementia progression using real-world clinical data.
  • The identified eight critical variables provide valuable insights for clinicians in guiding dementia patient management.